Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity.
The onset, duration, and offset of pemoline action to improve cognitive performance is examined intensively in 25 prepubescent males suffering from attention-deficit disorder with hyperactivity (ADDH). The purpose was to characterize the pharmacodynamics of pemoline in ADDH patients through correlation of plasma pemoline concentration with psychometric measures of memory search efficiency and paired-associates learning, with the physiological effect of pemoline on dopaminergic transmission concurrently measured by analysis of plasma prolactin response. The effect of pemoline on neuroprocessing is apparent within the first 2 hours after administration with an inverse relationship between plasma pemoline and prolactin concentration present at hour one only (r = 0.84; p = 0.005). Pemoline therapy for 3 weeks does not significantly affect area under the curve for pemoline or prolactin nor did the effect on memory search efficiency decrease, suggesting no apparent tolerance.
Sallee
F R
FR
Department of Psychiatry, Medical University of South Carolina, Charleston 29425.
Stiller
R L
RL
Perel
J M
JM
D001288:Attention / Q000187:drug effects* / Q000502:physiology; D001289:Attention Deficit Disorder with Hyperactivity / Q000097:blood* / Q000188:drug therapy / Q000523:psychology; D002648:Child; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008297:Male; D008657:Metabolic Clearance Rate; D008774:Methylphenidate / Q000008:administration & dosage / Q000493:pharmacokinetics; D009043:Motor Activity / Q000187:drug effects* / Q000502:physiology; D010153:Paired-Associate Learning / Q000187:drug effects / Q000502:physiology; D010389:Pemoline / Q000008:administration & dosage / Q000493:pharmacokinetics*
D008774:Methylphenidate; D010389:Pemoline